{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047617","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2024-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.438920+00:00","generated_at":"2026-05-29T18:47:59.152605+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"InspireMD appoints medtech executive Scott R. Ward to Board of Directors","bullets":["Scott R. Ward, former CEO of Cardiovascular Systems and Abbott leader, joins as Class II director.","Ward received options for 16,647 shares and 43,548 restricted stock, vesting on one-year anniversary.","Management highlights Ward's cardiovascular expertise ahead of potential U.S. approval of CGuard Prime.","Ward has over 40 years healthcare experience, including 30 years at Medtronic in senior leadership roles."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047617","json":"https://secwatch.observer/filing/0001493152-24-047617.json","markdown":"https://secwatch.observer/filing/0001493152-24-047617.md","text":"https://secwatch.observer/filing/0001493152-24-047617.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/0001493152-24-047617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T18:47:59.152605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f2860f0fa","claim":"Scott R. Ward was appointed as Class II member of the Board at InspireMD, Inc..","evidence_excerpt":"On November 25, 2024, the board of directors of InspireMD, Inc. (the “Board” and the “Company”, respectively) appointed Mr. Scott R. Ward as a Class II member of the Board, effective as of that date, with a term expiring at the Company’s 2025 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/0001493152-24-047617-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}